Your session is about to expire
← Back to Search
Text Messaging Dietary Intervention for Colorectal Cancer Survivors
N/A
Waitlist Available
Led By Erin Van Blarigan, ScD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 12 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial tests if a tailored text message intervention can help CRC survivors eat more whole grain foods & less refined grain foods, which may reduce their risk of death.
Who is the study for?
This trial is for English or Spanish-speaking adults over 18 who have had colon or rectal adenocarcinoma, are not currently on cancer treatment, and own a mobile phone. They should eat grains but less than half of their grain intake is whole grains, and they must be fully recovered from any major surgeries at least 6 weeks prior.
What is being tested?
The study tests if personalized text messages can help colorectal cancer survivors increase their whole grain consumption. It involves sending tailored dietary advice via texts along with surveys to monitor progress and provide nutrition education.
What are the potential side effects?
Since this intervention involves only text messaging and educational content about diet, there are no direct medical side effects expected from participating in this trial.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 12 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Feasibility of Intervention Measure (FIM)
Median response rate to text messages
Overall median score on the System Usability Scale (SUS)
+2 moreSecondary study objectives
Change in mean total daily fiber intake (g/d) reported on the Food Frequency Questionnaire (FFQ)
Change in percent of grains that are whole reported on the Food Frequency Questionnaire (FFQ)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Text message interventionExperimental Treatment3 Interventions
Adaptive 12-week text message intervention using reinforcement learning to increase whole grain and reduce refined grain intake. Participants will also complete semi-structured follow-up interviews and study related questionnaires.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dietary intervention via Text Messaging
2023
N/A
~50
Nutrition Education
2018
Completed Phase 3
~7810
Find a Location
Who is running the clinical trial?
University of California, San FranciscoLead Sponsor
2,593 Previous Clinical Trials
14,887,902 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,958 Previous Clinical Trials
41,112,532 Total Patients Enrolled
Erin Van Blarigan, ScDPrincipal InvestigatorUniversity of California, San Francisco
3 Previous Clinical Trials
1,092 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am older than 18 years.I have been diagnosed with colon or rectal cancer.I can speak and read either English or Spanish.I had major surgery over 6 weeks ago and have fully recovered.I am not currently undergoing cancer treatment and don't plan to start any during the study.
Research Study Groups:
This trial has the following groups:- Group 1: Text message intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.